Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drugs - Generic Sector (CIX: MSECTOR512)
2,403.59   -11.52 (-0.48%)
Streaming Delayed Price  /  Updated: 1:45 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Sector News
Press releases about Drugs - Generic Sector
 
"Modern Family" Star Julie Bowen Calls on Communities to Raise Their Hand for Anaphylaxis Awareness in Nationwide Competition
Today 9:30 EDT
Total of $60,000 Will Be Awarded to School Districts In Educational Grants Recommended for Anaphylaxis Education Read More
from PR Newswire
Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Litigation Relating to Sunovion's Brovana® Product
Today 7:30 EDT
from PR Newswire
Mylan Launches Generic Tricor® Tablets
May 17, 2013
from PR Newswire
Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results
May 16, 2013
from GlobeNewswire News Releases
Perfect Trade Setups, How to Play LUV, CMCSA, XOM and MYL
May 15, 2013
from Marketwired News Releases
Mylan Launches Generic Zomig® Tablets
May 15, 2013
from PR Newswire
Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy
May 10, 2013
More Than 65 Family-Friendly Walks Raise Food Allergy Awareness Read More
from PR Newswire
Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 09, 2013
from Business Wire News Releases
Free Research Reports on MYL, SPWR, SWN and WFT Issued by the Paragon Report
May 06, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
May 02, 2013
Reaffirms 2013 Adjusted Diluted EPS Guidance Range of $2.75 - $2.95 Read More
from PR Newswire
Deborah Autor, FDA's Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan
April 30, 2013
from PR Newswire
ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO
April 30, 2013
from Business Wire News Releases
Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference
April 29, 2013
from Business Wire News Releases
Mylan Specialty L.P. Announces 25th Anniversary Celebration of EpiPen® (epinephrine) Auto-Injector
April 25, 2013
Marketer of EpiPen® Auto-Injector, the No. 1 prescribed epinephrine auto-injector, announces additional efforts to increase anaphylaxis awareness, preparedness and access to treatment for those... Read More
from PR Newswire
Catalyst Pharmaceutical Partners Inc is Featured as the Daily Stock to Watch on Smallcappower.com
April 22, 2013
from Newsfile Corp News Releases
Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund
April 22, 2013
Pledge Supports Campaign's Goal to Raise Additional $90 Million for Scholarships over Next Two Years Read More
from PR Newswire
The Market Slips Lower and eBay Falls on Earnings Outlook
April 19, 2013
from PR Newswire
Mylan Schedules First Quarter 2013 Financial Results Conference Call and Live Webcast
April 09, 2013
from PR Newswire
Mylan, Akorn, Astex Pharma, and Forest Laboratories Under StockCall's Microscope
April 08, 2013
from PR Newswire
Before the Crowd, How We Found MYL, TXN, DIS and NEM
April 05, 2013
from Marketwired News Releases
Mylan Launches First Generic Version of Zovirax® Ointment
April 03, 2013
from PR Newswire
Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2012 Financial Results
April 02, 2013
from GlobeNewswire News Releases
Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)
March 27, 2013
from GlobeNewswire News Releases
The Real Story Behind MYL, JCI, NVS and WMB
March 19, 2013
from Marketwired News Releases
Mylan Launches Generic Version of Xopenex® Inhalation Solution
March 18, 2013
from PR Newswire
Mylan Announces Fortamet® Settlement Agreement
March 13, 2013
from PR Newswire
Strategy Behind Our Success, We Get in Early: MYL, CF, LOW and LLY
March 12, 2013
from Marketwired News Releases
InnoPharma Inc. Announces Launch of Generic Cidofovir Injection in the United States
March 08, 2013
from GlobeNewswire News Releases
Before the Bell Scans of Mylan, Forest Laboratories, Avanir Pharma, Akorn, and Medicines Co.
March 08, 2013
from PR Newswire
Catalyst Pharmaceutical Partners to Present at 25th Annual ROTH Conference
March 07, 2013
from GlobeNewswire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here